Free Trial
CVE:SN

Sennen Potash (SN) Stock Price, News & Analysis

C$0.15 -0.01 (-6.25%)
As of 02/17/2023

About Sennen Potash Stock (CVE:SN)

Key Stats

Today's Range
C$0.15
C$0.15
50-Day Range
C$0.15
C$0.15
52-Week Range
C$0.15
C$0.45
Volume
5,000 shs
Average Volume
12,780 shs
Market Capitalization
C$1.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sennen Potash and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SN Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Arab Potash Co.
See More Headlines

SN Stock Analysis - Frequently Asked Questions

Sennen Potash's stock was trading at C$0.15 at the start of the year. Since then, SN stock has increased by 0.0% and is now trading at C$0.15.

Shares of SN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sennen Potash investors own include Life Time Group (LTH), Merck & Co., Inc. (MRK), Marvell Technology (MRVL), PayPal (PYPL), Axalta Coating Systems (AXTA), American Express (AXP) and American Water Works (AWK).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Industrial Metals & Minerals
Sub-Industry
N/A
Current Symbol
CVE:SN
CIK
N/A
Fax
N/A
Employees
312
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-636.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
450.00
Book Value
C($0.13) per share
Price / Book
-1.15

Miscellaneous

Outstanding Shares
10,250,000
Free Float
N/A
Market Cap
C$1.54 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:SN) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners